Status:
COMPLETED
Neuropathic Pain in Jamaicans With Sickle Cell Disease
Lead Sponsor:
The University of The West Indies
Collaborating Sponsors:
Avicanna Inc
Conditions:
Sickle Cell Disease
Neuropathic Pain
Eligibility:
All Genders
14+ years
Brief Summary
Pain is the most common component of the morbidity seen in sickle cell disease (SCD), and may be acute or chronic. It is most commonly acute and a result of the hallmark vaso-occlusive episodes of the...
Detailed Description
All study participants will complete all the questionnaires provided, specifically the Adult Sickle Cell Quality of Life Measurement Information (ASCQ-Me), Leeds Assessment of Neuropathic Symptoms and...
Eligibility Criteria
Inclusion
- Patients aged 14 and older, of any sex and genotype
- Informed consent/parental consent with child assent available
- In well state at time of study
Exclusion
- Prior cerebrovascular accidents
- Acute illness at time of recruitment
- Current Pregnancy
Key Trial Info
Start Date :
July 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT04015401
Start Date
July 15 2019
End Date
July 1 2020
Last Update
April 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caribbean Institute for Health Research
Kingston, Jamaica, Kingston 7